Previous 10 | Next 10 |
Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI Cancers Symposium - DKN-01 plus tislelizumab demonstrated encouraging clinical activity in both first- and second-line advanced gastric or gastroesophageal juncti...
Growth stocks, on balance, have fallen out of favor in recent months. Political gridlock in Washington, D.C., historically high inflation rates, and concerns about an interest rate increase have dampened investors' appetite for risk. This negative sentiment, though, doesn't mean there aren'...
Penny stocks are something that retail traders have flocked to over the last few years. Since the pandemic, people find it isn’t as hard to make money in the stock market as they initially thought. That’s thanks, in part, to these newbies taking time to learn about other w...
Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference PR Newswire CAMBRIDGE, Mass. , Jan. 5, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics,...
Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Jan. 3, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeuti...
Short squeeze stocks are becoming a mainstay in the arsenal of trends to follow this year. Thanks to extensive breakouts from the likes of AMC Entertainment ( NYSE: AMC ), GameStop ( NYSE: GME ), and countless others, retail traders, in particular, are on the hunt for the next r...
Shares of this small oncology company have risen by 45% over the past three months, yet are down 10% over the past month. One goal for both myself and readers is to cultivate the ability to rapidly identify highly asymmetric setups - LPTX fits that description after ESMO data in gastr...
3 Biotech Penny Stocks to Watch With the New Variant in Mind With another interesting day of trading penny stocks and blue chips off to a good start, it’s clear that volatility is here to stay. Although it may have seemed like things were calming down in the past few weeks, the e...
Longeveron LGVN +101% after Rare Pediatric Disease Designation for candidate Mammoth Energy Services TUSK +29% on EV charging contract Gracell Biotechnologies GRCL +26% on FDA Orphan Drug tag for GC012F BioHiTech Global BHTG +19% on Q3 results UWM Holdi...
Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Nov. 15, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and ...
News, Short Squeeze, Breakout and More Instantly...
Leap Therapeutics Inc. Company Name:
LPTX Stock Symbol:
NASDAQ Market:
Leap Therapeutics Inc. Website:
Leap Therapeutics Reports First Quarter 2024 Financial Results PR Newswire CAMBRIDGE, Mass. , May 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today report...
Leap Therapeutics Announces $40 Million Private Placement PR Newswire Net proceeds, along with existing cash, cash equivalents, and marketable securities are expected to extend cash runway into Q2 2026 and enable expansion of DKN-01 DeFianCe clinical trial and development prog...
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...